# OnCo record threshold-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/threshold-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "threshold-pharmaceuticals" ;
  schema:name "Threshold Pharmaceuticals"@en ;
  schema:alternateName "Threshold Pharmaceuticals, Inc."@en ;
  schema:description "Threshold developed evofosfamide, a drug switched on only in the oxygen-starved parts of tumours; two phase 3 trials in pancreatic cancer and sarcoma failed in 2015 and the company merged away."@en ;
  schema:url <https://onco.cc/companies/threshold-pharmaceuticals/>, <http://www.thresholdpharm.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://www.thresholdpharm.com>, <https://clinicaltrials.gov/search?lead=Threshold%20Pharmaceuticals%2C%20Inc.>, <https://www.wikidata.org/wiki/Q30289027> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/hypoxia-activated-therapy/> ;
  onco:drugs <https://onco.cc/drugs/evofosfamide/> ;
  onco:companies <https://onco.cc/companies/merck-kgaa/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .